From: The developmental origins of sex-biased expression in cardiac development
Transcription factors and epigenetic and remodelling enzymes | ES | CP | 8.5 | 9.5 | 10.5 | p1 | Adult | Chr | Name |
---|---|---|---|---|---|---|---|---|---|
Egr4 | XY | Â | Â | Â | Â | Â | Â | 6 | Early growth response 4 |
Cdx1 | XY | Â | Â | Â | Â | Â | Â | 18 | Caudal type homeobox 1 |
E2f7 | XY | Â | Â | Â | Â | Â | Â | 10 | E2F transcription factor 7 |
Eomes | XY | Â | Â | Â | Â | Â | Â | 9 | Eomesodermin |
Evx1 | XY | Â | Â | Â | Â | Â | Â | 6 | Even-skipped homeobox 1 |
Foxi3 | XY | Â | Â | Â | Â | Â | Â | 6 | Forkhead box I3 |
Foxp4 | XY | Â | Â | Â | Â | Â | Â | 17 | Forkhead box P4 |
Insm1 | XY | Â | Â | Â | Â | Â | Â | 2 | Insulinoma-associated 1 |
Lin28a | XY | Â | Â | Â | Â | Â | Â | 4 | Lin-28 homolog A (C. elegans) |
Mesp1 | XY | Â | Â | Â | Â | Â | Â | 7 | Mesoderm posterior 1 |
Mixl1 | XY | Â | Â | Â | Â | Â | Â | 1 | Mix1 homeobox-like 1 (Xenopus laevis) |
Nr6a1 | XY | Â | Â | Â | Â | Â | Â | 2 | Nuclear receptor subfamily 5, group A, member 1 |
Pou2f3 | XY | Â | Â | Â | Â | Â | Â | 9 | POU domain, class 2, transcription factor 3 |
Sox11 | XY | Â | Â | Â | Â | Â | Â | 12 | SRY (sex determining region Y)-box 11 |
Sp5 | XY | Â | Â | Â | Â | Â | Â | 9 | Per-hexamer repeat gene 4 |
Sp8 | XY | Â | Â | Â | Â | Â | Â | 12 | Trans-acting transcription factor 8 |
T | XY | Â | Â | Â | Â | Â | Â | 17 | Brachyury, T-box transcription factor T |
Tcf7 | XY | Â | Â | Â | Â | Â | Â | 11 | Transcription factor 7, T cell specific |
Wiz | XY | Â | Â | Â | Â | Â | Â | 17 | Widely-interspaced zinc finger motifs |
Ybx2 | XY | Â | Â | Â | Â | Â | Â | 11 | Y box protein 2 |
Zglp1 | XY | Â | Â | Â | Â | Â | Â | 9 | Zinc finger, GATA-like protein 1 |
Dnmt3b | XY | Â | Â | Â | Â | Â | Â | 2 | DNA methyltransferase 3B |
Dnmt3l | XY | Â | Â | Â | Â | Â | Â | 10 | DNA (cytosine-5-)-methyltransferase 3-like |
Phc1 | XY | Â | Â | Â | Â | Â | Â | 6 | Polyhomeotic 1 |
Plac8 | XY | Â | Â | Â | Â | Â | Â | 5 | Placenta-specific 8 |
Tdrd5 | XY | Â | Â | Â | Â | Â | Â | 1 | Tudor domain containing 5 |
Bahcc1 | XY | Â | Â | Â | Â | Â | Â | 11 | BAH domain and coiled-coil containing 1 |
Kdm6c | XY | XY | XY | XY | XY | Â | XY | Y | Ubiq.transcribed tetratricopeptide repeat gene, Y chr |
Bcl6b | XY | XY | Â | Â | Â | Â | nb | 11 | B cell CLL/lymphoma 6, member B |
Irf8 | XY | XY | Â | Â | Â | Â | nb | 8 | Interferon regulatory factor 8 |
Arid1a | XY | XY | Â | Â | Â | Â | Â | 4 | AT rich interactive domain 1A (SWI-like) |
Lef1 | XY | Â | XY | Â | Â | XY | XY | 3 | Lymphoid enhancer binding factor 1 |
Tbx20 | XY | XY | Â | Â | XY | XY | Â | 9 | T-box 20 |
Smarcd1 | XY | Â | Â | Â | Â | XY | Â | 15 | SWI/SNF related, matrix assoc., actin-dep. reg. of chromatin d1 |
Zbtb7a | XY | Â | Â | Â | Â | XY | Â | 10 | Zinc finger and BTB domain containing 7a |
Hif3a | XY | XY | Â | Â | Â | XY | Â | 7 | hypoxia inducible factor 3, alpha subunit |
Nfkb2 | XY |  |  |  |  | XY | XY | 19 | nuclear factor of κ light polypeptide enhancer B cells 2, p49/p100 |
Pbx2 | XY | Â | Â | Â | Â | XY | nb | 17 | Pre B cell leukemia homeobox 2 |
Prdm6 | XY | Â | Â | Â | Â | Â | XY | 18 | PR domain containing 6 |
Id2 | XY | Â | Â | Â | Â | Â | XY | 12 | Inhibitor of DNA binding 2 |
Dot1l | XY | Â | Â | Â | Â | XY | XX | 10 | DOT1-like, histone H3 methyltransferase (S. cerevisiae) |
Zfp296 | XY | Â | Â | Â | Â | XX | Â | 7 | Zinc finger protein 296 |
Gata4 | XY | Â | Â | Â | Â | Â | nb | 14 | GATA binding protein 4 |
Mycn | XY | Â | Â | Â | Â | Â | nb | 12 | v-myc avian myelocytomatosis related og, neuroblastoma derived |
Hdac5 | XY | Â | Â | Â | Â | Â | nb | 11 | Histone deacetylase 5 |
Nfxl1 | XY | Â | Â | Â | Â | Â | nb | 5 | Nuclear transcription factor, X-box binding-like 1 |
Pax6 | nb | XY | Â | Â | Â | Â | Â | 2 | Paired box 6 |
Brd4 | nb | XY | Â | Â | Â | Â | nb | 17 | Bromodomain containing 4 |
Carhsp1 | nb | Â | XY | Â | Â | XY | XY | 16 | Calcium regulated heat stable protein 1 |
Csde1 | nb | Â | XY | XY | Â | nb | nb | 3 | Cold shock domain containing E1, RNA binding |
Mef2d | nb | Â | Â | Â | Â | XY | Â | 3 | Myocyte enhancer factor 2D |
Atf5 | nb | Â | Â | Â | Â | Â | XY | 7 | activating transcription factor 5 |
Bach2 | nb | Â | Â | Â | Â | Â | XY | 4 | BTB and CNC homology, basic leucine zipper transcription factor 2 |
Cdc5l | nb | Â | Â | Â | Â | Â | XY | 17 | Cell division cycle 5-like (S. pombe) |
Crebzf | nb | Â | Â | Â | Â | Â | XY | 7 | CREB/ATF bZIP transcription factor |
Gm13139 | nb | Â | Â | Â | Â | Â | XY | 4 | Zinc finger protein 991 |
Hmgb1 | nb | Â | Â | Â | Â | Â | XY | 2 | Predicted gene, 21596 |
Hmgb2 | nb | Â | Â | Â | Â | Â | XY | 8 | High mobility group box 2 |
Klf10 | nb | Â | Â | Â | Â | Â | XY | 15 | Kruppel-like factor 10 |
Nfic | nb | Â | Â | Â | Â | Â | XY | 10 | Nuclear factor I/C |
Nfkb1 | nb |  |  |  |  |  | XY | 3 | Nuclear factor of κ light polypeptide enhancer in B cells 1, p105 |
Pias2 | nb | Â | Â | Â | Â | Â | XY | 18 | Protein inhibitor of activated STAT 2 |